pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 6·1 min read
save

ACA enrollment falls sharply, with Ohio and Oklahoma each losing about a third of participants

Jul 6, 2026·read at STAT ↗RegulatoryNegative

New federal data shows steep drops in Affordable Care Act enrollment across the United States, with Ohio and Oklahoma each losing nearly one‑third of their participants.

Overall, about 2.6 million fewer Americans were covered by Obamacare plans in February compared with the same month last year, following the January expiration of enhanced subsidies.

The dataset, released by the Trump administration in late June and reviewed by KFF, captures new sign‑ups, automatic reenrollments and premium payments, including retroactive removals after grace periods, confirming expectations of a significant decline.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Obamacare rolls shrank dramatically in many states over the past year, new federal data shows”

read at STAT ↗
970 words · retrieved Jul 6
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING
topics
GLP-1 receptorOphthalmology

related stories

  • Jul 23Roche's late stage pipeline 'so full,' CEO Schinecker not feeling pressure to add onBioSpace
  • Jul 23Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clearFierce Biotech
  • Jul 23Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapiesFierce Biotech
  • Jul 21Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesityBioSpace
  • Jul 21Opinion: Pete Hegseth, ‘The Odyssey,’ and the testosterone mythSTAT